Gene Polymorphisms of Interleukin-27 Correlate with the Susceptibility, Severity, and Clinical Outcomes of Elderly People with Guillain-Barré Syndrome

Gerontology ◽  
2021 ◽  
pp. 1-7
Author(s):  
Huifang Zhang ◽  
Hongying Zhao ◽  
Guotao Yang ◽  
Ying Li ◽  
Yunfeng Liu

<b><i>Introduction:</i></b> Guillain-Barré syndrome (GBS) is a common autoimmune disease in the peripheral nervous system. This study aimed to elucidate the role of IL-27 gene polymorphisms in elderly people with GBS. <b><i>Methods:</i></b> A total of 395 healthy subjects and 422 GBS patients with an average age of 63 years old were included in this study. Peripheral blood samples were collected. The 2 single-nucleotide polymorphisms (SNPs) of IL-27, namely, rs153109 and rs785575, of GBS patients were analyzed using the PCR method and compared with those of the healthy controls. The correlations of IL-27 SNPs with disease severity, disease outcome, level of anti-GM1 antibodies, and <i>Campylobacter jejuni</i> infection were assessed. Serum levels of IL-27 of healthy subjects and GBS patients were analyzed using enzyme-linked immunosorbent assay. <b><i>Results:</i></b> No significant differences in the frequencies of rs785575 SNPs between GBS and healthy subjects were observed. In analyzing rs153109 SNPs, the G allele was found to be more prevalent in the GBS patients (<i>p</i> = 0.012). More alleles show GG genotype in GBS patients (<i>p</i> = 0.023). The −964A&#x3e;G allele has a higher prevalence in severely affected and anti-GM1-Ab-positive GBS patients. GBS patients with the rs153109 SNP showed a poor clinical outcome than those without rs153109 SNP (<i>p</i> = 0.012). GBS patients showed higher serum IL-27 levels than healthy subjects (<i>p</i> &#x3c; 0.001). The levels of IL-27 were also higher in GBS patients with genotypes of AG and GG, and those with GG genotypes showed the highest IL-27 levels. <b><i>Conclusion:</i></b> The rs153109 SNP is more prevalent in GBS patients with the GG and G allele and is associated with severer GBS, poorer clinical outcomes, and higher IL-27 levels.

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Shujuan Li ◽  
Ming Yu ◽  
Haifeng Li ◽  
Hongliang Zhang ◽  
Yanfang Jiang

Guillain-Barré syndrome (GBS) is an acute autoimmune-mediated inflammatory demyelinating disease that causes rapidly progressing paralysis and occasionally respiratory failure. We hypothesized that interleukin (IL)-17 and IL-22 are elevated in GBS and participate in the autoimmune inflammatory response of GBS. We used sandwich enzyme-linked immunosorbent assay (ELISA) to measure the IL-17 and IL-22 levels in the CSF, and plasma from 22 GBS patients at the acute phase and 18 healthy controls (HC). The results show that CSF and plasma levels of IL-17 and IL-22 are elevated in GBS patients compared with HC. IL-17 and IL-22 levels in CSF, respectively, are correlated with GBS disability scale scores (GDSs). Meanwhile, IL-17 and IL-22 levels in CSF, IL-22 in CSF, and plasma of GBS patients have positive correlation, respectively. The increased levels of IL-17 and IL-22 in CSF may be explained by the disruption of blood-brain barrier (BBB) and peripheral nervous system (PNS) local inflammation in GBS. Meanwhile, the elevated levels of these two cytokines in plasma suggest the activation of Th17 and Th22 cells in the systemic immune response of GBS. Our data provide preliminary evidence that GBS is associated with high levels of IL-17 and IL-22 in CSF and plasma. These cytokines display pathogenic potential and may serve as useful biomarkers for GBS.


2018 ◽  
Vol 7 (1) ◽  
pp. 1-4 ◽  
Author(s):  
Aileen Y. Chang ◽  
Rebecca Lynch ◽  
Karen Martins ◽  
Liliana Encinales ◽  
Andrés Á. Cadena Bonfanti ◽  
...  

Medicine ◽  
2017 ◽  
Vol 96 (15) ◽  
pp. e6618 ◽  
Author(s):  
Zhongqian Su ◽  
Zhibo Chen ◽  
Yian Xiang ◽  
Bingjie Wang ◽  
Yuanyuan Huang ◽  
...  

Neurology ◽  
1998 ◽  
Vol 51 (2) ◽  
pp. 379-384 ◽  
Author(s):  
J. J. Ma ◽  
M. Nishimura ◽  
H. Mines ◽  
S. Kuroki ◽  
M. Nukina ◽  
...  

Objective: We examined a possible involvement of genetic factors influencing the development of Guillain-Barré syndrome (GBS).Methods: We studied T-cell receptor (TCR), alpha-chain constant (AC), and beta-chain variable (BV) gene polymorphisms using microsatellite markers and serologic HLA class I antigens, HLA-DRB1, and HLA-DQB1 alleles in 81 Japanese patients with GBS and 87 controls.Results: There were no significant differences in these genetic markers between GBS patients and controls. Subgrouping of GBS patients according to recent Campylobacter jejuni infection, the presence of anti-GM1 antibody in the sera, or their combinations also failed to reveal significant associations with these genetic markers. There was, however, a tendency for an increased frequency of HLA-DRB1*0803 in the C. jejuni + GM1 + GBS group, when compared with controls.Conclusions: The data suggest that the roles of TCRAC, T-cell receptor beta-chain variable (TCRBV), HLA class I or class II in the development of GBS are not critical, and further research is necessary to clarify other genes encoded within the HLA region for genetic susceptibility to GBS.


2018 ◽  
Vol 314 ◽  
pp. 8-12 ◽  
Author(s):  
Mohammad I. Rahman ◽  
Iffat Jahan ◽  
Mir M. Khalid ◽  
Israt Jahan ◽  
Rijwan U. Ahammad ◽  
...  

2019 ◽  
Vol 41 (2) ◽  
pp. 295-303 ◽  
Author(s):  
Chunrong Li ◽  
Tianfei Luo ◽  
Yanwei Cheng ◽  
Shan Liu ◽  
Lifan Qiao ◽  
...  

2008 ◽  
Vol 205 (1-2) ◽  
pp. 110-112 ◽  
Author(s):  
Mark L. Kuijf ◽  
Karin Geleijns ◽  
Noureddine Ennaji ◽  
Wouter van Rijs ◽  
Pieter A. van Doorn ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document